INSMED INC Other Assets
INSMED INC (INSM) had Other Assets of $104.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2026-08-06
- 2026-06-30: Other Assets $104.44M.
- 2026-03-31: Other Assets $99.28M.
- 2025-12-31: Other Assets $97.38M.
- 2025-09-30: Other Assets $91.61M.
| Period end | Other Assets |
|---|---|
| 2026-06-30 | $104.44M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $99.28M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $97.38M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $91.61M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $88.81M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $89.76M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $93.23M 10-K · filed 2026-02-19 |
| 2024-09-30 | $96.86M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $85.83M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $95.70M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $96.57M 10-K · filed 2025-02-20 |
| 2023-09-30 | $92.49M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $83.44M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $81.32M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $76.10M 10-K · filed 2024-02-22 |
| 2022-09-30 | $63.71M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $66.30M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $57.20M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $50.99M 10-K · filed 2023-02-23 |
| 2021-09-30 | $47.60M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $49.24M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $46.36M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.77M 10-K · filed 2022-02-17 |
| 2020-09-30 | $25.21M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $23.61M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $21.91M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $20.31M 10-K · filed 2021-02-25 |
| 2019-09-30 | $19.64M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $16.46M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $11.31M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $4.30M 10-K · filed 2020-02-25 |
| 2018-09-30 | $4.55M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $2.90M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $2.72M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $1.97M 10-K · filed 2019-02-22 |
| 2017-09-30 | $1.55M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.67M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.03M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $1.33M 10-K · filed 2018-02-23 |
| 2016-09-30 | $1.87M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.37M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $2.12M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $2.15M 10-K · filed 2017-02-23 |
| 2015-09-30 | $231.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $231.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $417.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $416.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $418.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $420.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $234.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $323.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $101.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $104.00K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $110.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $117.00K 10-K · filed 2014-03-06 |
| 2012-09-30 | $125.00K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $133.00K 10-Q · filed 2012-08-07 |
| 2011-12-31 | $212.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |